Home » Topics » BioWorld Science

BioWorld Science
RSS

Study of CoV-OC43 dissemination in mouse CNS and drug testing using non-invasive bioluminiscence

Feb. 26, 2020

Aclaris Therapeutics patents ITK and JAK3 inhibitors

Feb. 26, 2020

Optimization and in vivo testing of bumetanide derivatives for temporal lobe epilepsy

Feb. 26, 2020

Trinucleotide expansions are too much of a good thing

Feb. 26, 2020

Preclinical data presented for scAAV9/CLN7 gene replacement therapy

Feb. 26, 2020

Pandion begins first-in-human trial of PT-101 for autoimmune disease

Feb. 26, 2020

Results from phase Ib portion of the CARTITUDE-1 study

Feb. 26, 2020

Circulating ANGPTL8 as a marker of metabolic disorders in PCOS

Feb. 26, 2020

DOTATATE uptake is higher in mCRPC patients with neuroendocrine transformation

Feb. 26, 2020

Sharper look yields new potential kinase target in ovarian cancer

Feb. 26, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...